Key Metrics
2.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Q3
Oncology
SJR
- Q3 Oncology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.62
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
6 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
1%
4 to 6 months
40%
7 to 9 months
52%
Above 9 months
7%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Myxoma virus
- Lung cancer
- Immunotherapy
- Immune checkpoint inhibitors
- Overall survival
- Soft tissue sarcoma
- Ribonucleotide reductase
- Objective response
- Melatonin
- Colorectal cancer
- Andrographolide
- Complete resection
- Disease progression
- Plasma samples
- Stable Disease
- Renal carcinoma
- Lung cancer surgery
- Oxaliplatin
Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2000 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 8 |
| Article Processing Charges | USD 2000 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Clinical Medicine Insights: Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Cost-Effectiveness Analysis of 6 Tyrosine Kinase Inhibitors as First-Line Treatment for ALK-Positive NSCLC in China.
- 1 Jan 24
- Clinical Medicine Insights. Oncology
-
Full paper
Risk Factors for Distant Metastasis in T3 T4 Rectal Cancer.
- 1 Jan 24
- Clinical Medicine Insights: Oncology
-
Full paper
Peripheral Coagulation Parameters and Prostate Cancer Association: A Retrospective Study and Mendelian Randomization.
- 1 Jan 24
- Clinical Medicine Insights. Oncology
-
Full paper
Unraveling the Mechanism of Action of Ubiquitin-Specific Protease 5 and Its Inhibitors in Tumors.
- 1 Jan 24
- Clinical Medicine Insights. Oncology
-
Full paper
Copper Chaperone for Superoxide Dismutase Subtypes as a Prognostic Marker in Luminal B Breast Cancer.
- 1 Jan 24
- Clinical Medicine Insights: Oncology
-
Full paper
RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review.
- 1 Jan 24
- Clinical Medicine Insights: Oncology
Scite analysis
Powered by scite_
466 articles received 4.8k citations see all
- 117 Supporting
- 4,566 Mentioning
- 17 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 3 Corrections
- 4 Errata
- 0 Expression of Concern
FAQs
How long has Clinical Medicine Insights: Oncology been actively publishing?
Clinical Medicine Insights: Oncology has been in operation since 2010 till date.
What is the publishing frequency of Clinical Medicine Insights: Oncology ?
Clinical Medicine Insights: Oncology published with a Continuous publication frequency.
How many articles did Clinical Medicine Insights: Oncology publish last years ?
In 2023, Clinical Medicine Insights: Oncology published 61 articles.
What is the eISSN & pISSN for Clinical Medicine Insights: Oncology ?
For Clinical Medicine Insights: Oncology,eISSN is 1179-5549 and pISSN is1179-5549.
What is Citescore for Clinical Medicine Insights: Oncology ?
Citescore for Clinical Medicine Insights: Oncology is 2.5.
What is SNIP score for Clinical Medicine Insights: Oncology ?
SNIP score for Clinical Medicine Insights: Oncology is 0.62.
What is the SJR for Clinical Medicine Insights: Oncology ?
SJR for Clinical Medicine Insights: Oncology is Q3.
Who is the publisher of Clinical Medicine Insights: Oncology ?
SAGE PUBLICATIONS LTD is the publisher of Clinical Medicine Insights: Oncology.